Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Gains Rights to Provide Pathology's Miscarriage Tests

NEW YORK (GenomeWeb News) – CombiMatrix said today that Pathology has chosen it to serve as the exclusive provider of Pathology's chromosomal microarray tests for the products of conception testing market in the US.

The deal expands an earlier strategic partnership between the firms forged late last year that provided Pathology with the right to market and distribute CombiMatrix's microarray tests in California and Nevada, as well as St. Louis and Chicago. Products of conception testing is also called miscarriage testing and is a subset of the prenatal testing market.

"We believe this market is going to continue to expand as our physician customers and their patients realize the importance of microarray testing in helping to identify the causes of miscarriages and how that information may assist in future pregnancies," Pathology President and CEO Vicki DiFrancesco said in a statement.

CombiMatrix President and CEO Mark McDonough added that the expansion of the firms' earlier deal "underscores the rapidly expanding importance of microarray testing and the value our team brings to Pathology in terms of operational and analytical support." He said that the deal with Pathology "allows us to extend our customer base of Ob/Gyns and provides us with additional marketing and distribution support."

Financial and other terms were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.